Douglas Reed

Director/Board Member at

Viamet Pharmaceuticals Corp.

72 year

75 connections

Health Technology

Finance

Consumer Services

Profile

Douglas W.
Reed currently works at Innocrin Pharmaceuticals Holdings LLC, as Chairman from 2014, Viamet Pharmaceuticals, Inc., as Director from 2007, Contego Medical, Inc., as Director, Viamet Pharmaceuticals Corp., as Director from 2011, Southeast BIO, as Director from 2009, Innocrin Pharmaceuticals, Inc., as Director, Standard Bariatrics, Inc., as Director, Qpex Biopharma, Inc., as Director, Hatteras Venture Affiliates III LP, as General Partner, and Hatteras Venture Partners, as General Partner from 2007.
Dr. Reed also formerly worked at Star Equity Holdings, Inc., as Director from 2000 to 2009, PhaseBio Pharmaceuticals, Inc., as Director, TetraLogic Pharmaceuticals Corp., as Independent Director from 2010 to 2016, SpineAlign Medical, Inc., as Director, BlinkBio, Inc., as Director, NeuroTronik, Inc., as Director, Sideris Pharmaceuticals, Inc., as Director, Gilead Connecticut, Inc., as Director from 2001 to 2010, Vector Asset Management, Inc., as Managing Director, Embrella Cardiovascular, Inc., as Director from 2009 to 2011, First National Bank of Crossett (Arkansas), as Director, NPS Pharmaceuticals, Inc., as Vice President-Business Development from 1996 to 1997, GelTex Pharmaceuticals, Inc., as Vice President-Business Development in 1999, GSK Equity Investments Ltd, as Principal, and the University of Washington, as Assistant Professor in 1983.
Dr. Reed received his undergraduate degree in 1977 and doctorate degree in 1978 from the University of Missouri-Kansas City and Masters Business Admin degree in 1989 from The Wharton School of the University of Pennsylvania.

Douglas Reed active positions

Companies	Position	Start
Qpex Biopharma, Inc. Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery, development and regulatory services for clinical-stage biopharmaceutical company	Director/Board Member	-
Innocrin Pharmaceuticals Holdings LLC Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Discovers and develops oral inhibitors for the treatment of castration-resistant prostate cancer	Chairman	2013-12-31
Innocrin Pharmaceuticals, Inc. Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer	Director/Board Member	-
Contego Medical, Inc. Contego Medical, Inc. Medical SpecialtiesHealth Technology Manufactures carotid and angioplasty systems	Director/Board Member	-
Southeast BIO	Director/Board Member	2008-12-31
Viamet Pharmaceuticals, Inc. Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes	Director/Board Member	2007-04-30
Hatteras Venture Affiliates III LP Hatteras Venture Affiliates III LP Investment ManagersFinance Acts as Venture Capital Fund	Corporate Officer/Principal	-
Viamet Pharmaceuticals Corp. Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry	Director/Board Member	2011-11-30
Hatteras Venture Partners Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments.	Private Equity Investor	2006-12-31
░░░░░░░░ ░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

All active positions of Douglas Reed

Former positions of Douglas Reed

Companies	Position	End
░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Douglas Reed's experience

Training of Douglas Reed

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Douglas Reed's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	27
NPS Pharmaceuticals, Inc. NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases	Health Technology
GelTex Pharmaceuticals, Inc. GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals	Health Technology
Star Operating Cos., Inc. Star Operating Cos., Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures diagnostic imaging solutions, gamma cameras and construction	Health Technology
PhaseBio Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases	Health Technology
Viamet Pharmaceuticals, Inc. Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops inhibitors of validated metalloenzymes	Health Technology
TetraLogic Pharmaceuticals Corp. TetraLogic Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases	Health Technology
Hatteras Venture Affiliates III LP Hatteras Venture Affiliates III LP Investment ManagersFinance Acts as Venture Capital Fund	Finance
SpineAlign Medical, Inc. SpineAlign Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which develops implantable products to treat vertebral compression fractures	Health Technology
Contego Medical, Inc. Contego Medical, Inc. Medical SpecialtiesHealth Technology Manufactures carotid and angioplasty systems	Health Technology
BlinkBio, Inc. BlinkBio, Inc. Pharmaceuticals: MajorHealth Technology Develops orally active drugs that act like small drug molecules	Health Technology
Viamet Pharmaceuticals Corp. Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using proprietary metalloenzyme medicinal chemistry	Health Technology
NeuroTronik, Inc. NeuroTronik, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations	Health Technology
Sideris Pharmaceuticals, Inc. Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on development of therapeutics for the treatment of transfusion-related iron overload	Health Technology
Innocrin Pharmaceuticals Holdings LLC Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Discovers and develops oral inhibitors for the treatment of castration-resistant prostate cancer	Health Technology
GSK Equity Investments Ltd. GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements.	Finance
University of Washington University of Washington Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gilead Connecticut, Inc. Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and biotechnology chemicals	Health Technology
Hatteras Venture Partners Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments.	Finance
Southeast BIO
Vector Asset Management, Inc. Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management invests in later-stage private and public companies in the life sciences and healthcare industries. Specific areas of interest include: biotechnology, pharmaceuticals, medical devices, diagnostics, plant and animal sciences, healthcare services, healthcare information technology and consumer applications of emerging healthcare technologies. They focus on companies that are raising capital in the private markets prior to the point at which they can access the public markets or execute an alternative exit strategy. Vector looks for companies ready to move from development stage to commercially viable operating entities in a relatively short time. The firm also participates in equity transactions involving securities of small- to mid-cap public companies in the life sciences and healthcare area. Most of Vector's investments are negotiated directly with company management. Vector is an active investor and generally leads or co-leads their investments. They usually serve on the Board of Directors of their portfolio companies. Investments range from $5 million to $15 million with an investment horizon of one to three years.	Finance
Embrella Cardiovascular, Inc. Embrella Cardiovascular, Inc. Miscellaneous Commercial ServicesCommercial Services Develops proprietary systems for embolic cerebral protection during cardiovascular procedures	Commercial Services
University of Missouri-Kansas City University of Missouri-Kansas City Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
First National Bank of Crossett (Arkansas) First National Bank of Crossett (Arkansas) Major BanksFinance Nationally chartered commercial bank	Finance
The Wharton School of the University of Pennsylvania The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Innocrin Pharmaceuticals, Inc. Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oral inhibitors for the treatment of castration-resistant prostate cancer	Health Technology
Standard Bariatrics, Inc. Standard Bariatrics, Inc. Medical SpecialtiesHealth Technology Develops surgical instruments	Health Technology
Qpex Biopharma, Inc. Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery, development and regulatory services for clinical-stage biopharmaceutical company	Health Technology